Maghimaa Mathanmohun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maghimaa Mathanmohun has a total of 134 co-authors. Here are the top co-authors by number of shared publications:
Boojhana Elango
Department of Microbiology, Muthayammal College of Arts and Science, Affiliated to Periyar University, Rasipuram, Namakkal, Salem, India
10 shared publicationsKarthikeyan Murugesan
Department of Microbiology, Faculty of Medicine and Health Sciences Quest International University Perak Malaysia
10 shared publications- Kanthesh M. Basalingappa
JSS Academy of Higher Education and Research
6 shared publications Anjuna Radhakrishnan
Department of Microbiology, Faculty of Medicine and Health Sciences Quest International University Perak Malaysia
5 shared publicationsG. G. Swamy
Department of Pathology, Faculty of Medicine and Health Sciences, Quest International University, Malaysia
5 shared publicationsSrinivasan Ramasamy
Tamil Nadu State Council for Science & Technology, Chennai, India
5 shared publications
Latest Publications
- 2 July 2026
- Published by Springer Nature
- p. 171-197
Bionanofactories for Green Synthesis of Nanoparticles: Toward Biomedical Applications
- 2 July 2026
- Published by Springer Nature
- p. 171-197
Bionanofactories for Green Synthesis of Nanoparticles: Toward Biomedical Applications
- 12 December 2025
- Published by Springer Nature in Water, Air, & Soil Pollution
- Vol. 237 (4) , 247
Addressing the Persistent Threat of Emerging Micropollutants: Innovative Treatment Technologies for Protecting Human Health and Ecosystem Stability
- 12 December 2025
- Published by Springer Nature in Water, Air, & Soil Pollution
- Vol. 237 (4) , 247
Addressing the Persistent Threat of Emerging Micropollutants: Innovative Treatment Technologies for Protecting Human Health and Ecosystem Stability
- 22 November 2025
- Published by Springer Nature in 3 Biotech
- Vol. 15 (12) , 430
Exploring the mechanisms of action of polyphenols in the treatment of cervical cancer
Globally, cervical cancer is the fourth most common cancer and remains a leading cause of cancer-related mortality in women. In this context, plant-derived compounds, especially polyphenols, are attracting increasing interest as potential therapeutic agents for the prevention and treatment of cervical cancer, with their various anticancer mechanisms. Interest in the study of dietary phytochemicals such as Flavonoids, Phenolic acids, Stilbenes, Lignans, Anthocyanidins and Proanthocyanidins has returned as a result of recent emphasis on the significance of nutrition and its relationship to particular forms of neoplasia. Polyphenols have demonstrated a broad range of cellular effects: they can hinder carcinogens from entering the targeted sites, aid in reactive molecule detoxification, enhance the removal of transformed cells, boost immune surveillance, and most importantly, they can affect tumor suppressors and inhibit cellular proliferation, thereby interfering with the steps involved in the development of cancer. Since they disrupt the essential processes of cellular proliferation, differentiation, apoptosis, angiogenesis, Reactive Oxygen Species (ROS), Immunomodulation, Epigenetic modifications, migration and metastasis, certain dietary polyphenols have the potential to be very effective in the prevention and treatment of cervical cancer, according to the studies. Polyphenols inhibit the proliferation of HPV-infected cervical cells by inducing apoptosis, causing cell-cycle arrest, blocking DNA synthesis, and modulating signaling pathways. Numerous benefits of polyphenols as chemopreventive and chemotherapeutic agents for cervical cancer are highlighted in the review. Due to their profound influence on gene modification, polyphenols have a great deal of promise for preventing cervical cancer. Based on their effects on molecular signaling pathways and gene regulation, polyphenols may be important in both delaying the onset of cervical cancer and possibly affecting the disease progression.
- 22 November 2025
- Published by Springer Nature in 3 Biotech
- Vol. 15 (12) , 430
Exploring the mechanisms of action of polyphenols in the treatment of cervical cancer
Globally, cervical cancer is the fourth most common cancer and remains a leading cause of cancer-related mortality in women. In this context, plant-derived compounds, especially polyphenols, are attracting increasing interest as potential therapeutic agents for the prevention and treatment of cervical cancer, with their various anticancer mechanisms. Interest in the study of dietary phytochemicals such as Flavonoids, Phenolic acids, Stilbenes, Lignans, Anthocyanidins and Proanthocyanidins has returned as a result of recent emphasis on the significance of nutrition and its relationship to particular forms of neoplasia. Polyphenols have demonstrated a broad range of cellular effects: they can hinder carcinogens from entering the targeted sites, aid in reactive molecule detoxification, enhance the removal of transformed cells, boost immune surveillance, and most importantly, they can affect tumor suppressors and inhibit cellular proliferation, thereby interfering with the steps involved in the development of cancer. Since they disrupt the essential processes of cellular proliferation, differentiation, apoptosis, angiogenesis, Reactive Oxygen Species (ROS), Immunomodulation, Epigenetic modifications, migration and metastasis, certain dietary polyphenols have the potential to be very effective in the prevention and treatment of cervical cancer, according to the studies. Polyphenols inhibit the proliferation of HPV-infected cervical cells by inducing apoptosis, causing cell-cycle arrest, blocking DNA synthesis, and modulating signaling pathways. Numerous benefits of polyphenols as chemopreventive and chemotherapeutic agents for cervical cancer are highlighted in the review. Due to their profound influence on gene modification, polyphenols have a great deal of promise for preventing cervical cancer. Based on their effects on molecular signaling pathways and gene regulation, polyphenols may be important in both delaying the onset of cervical cancer and possibly affecting the disease progression.
- 1 November 2025
- Published by Springer Nature in Metabolomics
- Vol. 21 (6) , 1-17
Metabolomic characterization of algal nutraceuticals to elucidate their biological activities
Background Algal nutraceuticals have emerged as the valuable bioresources due to their various chemical compositions and potential health benefits. Algae contain many bioactive compounds, including polyphenols, polysaccharides, omega-3 fatty acids, pigments, and vitamins, which are vital for the various biological processes in the human body. Understanding these complex metabolites is essential for their application in functional foods, dietary supplements, and pharmaceuticals. In this context, metabolomics provides a comprehensive approach for analyzing algal metabolic profiles and their nutritional and medicinal values. Aim of review This review explores the role of metabolomics in the evaluation and development of algal nutraceuticals. It focuses particularly on the identification and characterization of small-molecule metabolites in algae, offering insights into their functional properties and bioactivities. This review also discusses the integration of metabolomics with other omics technologies to achieve a holistic understanding of the metabolism of algae. Key scientific concepts of review Metabolomic studies have successfully explored a wide range of bioactive compounds in algae with antioxidant, anti-inflammatory, anticancer, antibacterial, and neuroprotective activities. Techniques such as mass spectrometry (MS) and nuclear magnetic resonance (NMR) spectroscopy have advanced the detection and quantification of metabolites with high sensitivity and resolution, respectively. Additionally, metabolomics aids to determine the quality biomarkers and the assessment of algal nutritional content. Integrating metabolomics with genomics, proteomics, and transcriptomics will further elucidate the metabolic pathways and regulatory networks in algae. This review highlights the critical role of metabolomics in maximizing the utilization of algae for health benefits.
- 1 November 2025
- Published by Springer Nature in Metabolomics
- Vol. 21 (6) , 1-17
Metabolomic characterization of algal nutraceuticals to elucidate their biological activities
Background Algal nutraceuticals have emerged as the valuable bioresources due to their various chemical compositions and potential health benefits. Algae contain many bioactive compounds, including polyphenols, polysaccharides, omega-3 fatty acids, pigments, and vitamins, which are vital for the various biological processes in the human body. Understanding these complex metabolites is essential for their application in functional foods, dietary supplements, and pharmaceuticals. In this context, metabolomics provides a comprehensive approach for analyzing algal metabolic profiles and their nutritional and medicinal values. Aim of review This review explores the role of metabolomics in the evaluation and development of algal nutraceuticals. It focuses particularly on the identification and characterization of small-molecule metabolites in algae, offering insights into their functional properties and bioactivities. This review also discusses the integration of metabolomics with other omics technologies to achieve a holistic understanding of the metabolism of algae. Key scientific concepts of review Metabolomic studies have successfully explored a wide range of bioactive compounds in algae with antioxidant, anti-inflammatory, anticancer, antibacterial, and neuroprotective activities. Techniques such as mass spectrometry (MS) and nuclear magnetic resonance (NMR) spectroscopy have advanced the detection and quantification of metabolites with high sensitivity and resolution, respectively. Additionally, metabolomics aids to determine the quality biomarkers and the assessment of algal nutritional content. Integrating metabolomics with genomics, proteomics, and transcriptomics will further elucidate the metabolic pathways and regulatory networks in algae. This review highlights the critical role of metabolomics in maximizing the utilization of algae for health benefits.
- Open Access
- 1 September 2025
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 19 (3) , 2271-2291
Cocktail Antigen Presenting Peptide Vaccine Development for Nipah Virus: An Immunoinformatic Approach to Indian and Malaysian Strain
Nipah virus (NiV) is an emerging zoonotic pathogen of global concern, causing serious life-threatening illness in humans. The first outbreak was reported from Malaysia in 1998. The virus is classified under the family Paramyxoviridae. Geographically, the deadly virus is known to be distributed in Southeast Asia. Its recent emergence in Kerala, India, indicates its public health emergency and necessitates the urgent proactive measures for the development of a safe and effective vaccine for the prevention and control of the disease. As a single-stranded RNA virus, there is no effective antiviral or vaccine available to fight this virus. Attempt on the development of vaccines had been hampered due to the highly infectious nature of the virus and the requirement of specialised bio-containment facility to handle the pathogen. Considering the potential advantages of reverse vaccinology approaches, the present study attempted to predict vaccine candidates targeting NiV virus genes encoding non-structural and structural proteins (specifically glycoprotein G, glycoprotein F, and W protein) circulating in Southeast Asia. The results of the analysis have suggested two potential vaccine candidates based on various parameters such as antigenicity, immunogenicity, non-toxicity, and non-allergenicity. In view of the global interest on urgent requirement of an effective vaccine, the present study predicted candidate vaccine antigens using bioinformatic tools and their promising usefulness as candidate peptides along with ongoing vaccine discovery efforts has been discussed.
- 1 September 2025
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 19 (3) , 2271-2291
Open AccessCocktail Antigen Presenting Peptide Vaccine Development for Nipah Virus: An Immunoinformatic Approach to Indian and Malaysian Strain
Nipah virus (NiV) is an emerging zoonotic pathogen of global concern, causing serious life-threatening illness in humans. The first outbreak was reported from Malaysia in 1998. The virus is classified under the family Paramyxoviridae. Geographically, the deadly virus is known to be distributed in Southeast Asia. Its recent emergence in Kerala, India, indicates its public health emergency and necessitates the urgent proactive measures for the development of a safe and effective vaccine for the prevention and control of the disease. As a single-stranded RNA virus, there is no effective antiviral or vaccine available to fight this virus. Attempt on the development of vaccines had been hampered due to the highly infectious nature of the virus and the requirement of specialised bio-containment facility to handle the pathogen. Considering the potential advantages of reverse vaccinology approaches, the present study attempted to predict vaccine candidates targeting NiV virus genes encoding non-structural and structural proteins (specifically glycoprotein G, glycoprotein F, and W protein) circulating in Southeast Asia. The results of the analysis have suggested two potential vaccine candidates based on various parameters such as antigenicity, immunogenicity, non-toxicity, and non-allergenicity. In view of the global interest on urgent requirement of an effective vaccine, the present study predicted candidate vaccine antigens using bioinformatic tools and their promising usefulness as candidate peptides along with ongoing vaccine discovery efforts has been discussed.
- 15 May 2025
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 35 (4) , 698-714
Exploring Herbal Medicines for Human Infections Associated with Avian Influenza A Viruses: A Recent Outbreak
- 15 May 2025
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 35 (4) , 698-714
Exploring Herbal Medicines for Human Infections Associated with Avian Influenza A Viruses: A Recent Outbreak
- 5 May 2025
- Published by Springer Nature in Biomedical Materials & Devices
- Vol. 4 (2) , 2122-2137
Enhancing Antibacterial and Antibiofilm Activity Using Gymnema sylvestre Mediated Silver Nanoparticles: A Promising Approach in Infection Control
- 5 May 2025
- Published by Springer Nature in Biomedical Materials & Devices
- Vol. 4 (2) , 2122-2137
Enhancing Antibacterial and Antibiofilm Activity Using Gymnema sylvestre Mediated Silver Nanoparticles: A Promising Approach in Infection Control
- 25 March 2025
- Published by Springer Nature
- p. 83-115
Plant-Derived Biomaterial and Their Use in Cardiac Tissue Repair
- 25 March 2025
- Published by Springer Nature
- p. 83-115
Plant-Derived Biomaterial and Their Use in Cardiac Tissue Repair
- Open Access
- 27 September 2024
- Published by Manuscript Technomedia LLP in International Journal of Pharmaceutical Investigation
- Vol. 14 (4) , 1201-1207
Targeted Immunization Strategies and Designing Vaccine against Indian Nipah Virus Strain (NiV B) and Malaysian Variant (NiV M)
Background Nipah virus is a deadly infectious virus that was first isolated and identified from Malaysia. Since then, a number of Nipah virus outbreaks have been reported from Bangladesh and India. Transmission of the disease occurs through Pteropus genus fruit bats. The case fatality rate of this infection is very high when compared with other viral zoonoses. At present, there are no approved vaccines or drugs available to prevent or treat this infection. A number of studies are ongoing to develop an efficient vaccine candidate to combat this deadly virus. The majority of them concentrate on the structural and non-structural proteins, which are the main targets of neutralizing antibodies. Materials and Methods Here, we analyzed the genome sequence identity of two Nipah virus strains, Indian and Malaysian, and also the amino acid identity between the two structural proteins (Attachment glycoprotein G and Fusion protein F) and one non-structural protein (W protein) of those two strains. Results and Discussion It was found that there is a considerable amount of nucleotide sequence homology between the initial strain that originated from Malaysia and the strain that is now found in India. Furthermore, the Structural and Non-structural proteins of these two strains exhibit a high degree of similarity. Conclusion Hence, a vaccine candidate designed using either NiV M or NiV B can be effectively used as a potent vaccine.
- 27 September 2024
- Published by Manuscript Technomedia LLP in International Journal of Pharmaceutical Investigation
- Vol. 14 (4) , 1201-1207
Open AccessTargeted Immunization Strategies and Designing Vaccine against Indian Nipah Virus Strain (NiV B) and Malaysian Variant (NiV M)
Background Nipah virus is a deadly infectious virus that was first isolated and identified from Malaysia. Since then, a number of Nipah virus outbreaks have been reported from Bangladesh and India. Transmission of the disease occurs through Pteropus genus fruit bats. The case fatality rate of this infection is very high when compared with other viral zoonoses. At present, there are no approved vaccines or drugs available to prevent or treat this infection. A number of studies are ongoing to develop an efficient vaccine candidate to combat this deadly virus. The majority of them concentrate on the structural and non-structural proteins, which are the main targets of neutralizing antibodies. Materials and Methods Here, we analyzed the genome sequence identity of two Nipah virus strains, Indian and Malaysian, and also the amino acid identity between the two structural proteins (Attachment glycoprotein G and Fusion protein F) and one non-structural protein (W protein) of those two strains. Results and Discussion It was found that there is a considerable amount of nucleotide sequence homology between the initial strain that originated from Malaysia and the strain that is now found in India. Furthermore, the Structural and Non-structural proteins of these two strains exhibit a high degree of similarity. Conclusion Hence, a vaccine candidate designed using either NiV M or NiV B can be effectively used as a potent vaccine.